AI & Digital Health

AI-powered personalized wellness ecosystem integrating blood pressure, glucose trends, meditation, weight optimization, and behavioral coaching — without entering regulated clinical territory

August 10, 2025

By Dr. Ebot Eyong

At E&E Medicals, we are excited to introduce eeMeds™, an AI-powered preventative wellness platform designed to unify fragmented lifestyle apps into a single adaptive personalization engine focused on sleep, stress, weight trends, movement, and behavioral optimization.

Read The Article

Partner With Dr. Eyong

At E&E Medicals, we are excited to introduce eeMeds™, our AI-powered preventative wellness platform. This innovative solution aims to unify fragmented lifestyle apps into a single, adaptive personalization engine, which we call "The AI-powered Lifestyle Intelligence Platform, or Your Personal Wellness Data Brain."

eeMeds goes beyond static content by dynamically optimizing user behavior across key areas, including sleep, stress, weight trends, and movement. Our focus is solely on wellness, allowing for rapid development and scalability.

We are currently raising a seed round to fund the following initiatives:

MVP and AI prototype development
Core engineering and product hires
Early beta launch and validation
Initial user-acquisition testing
Strategic wearable and ecosystem integrations

Our target for this seed raise is [$2.5M – $4.0M], which will support 12–18 months of product development and market validation. Our goal is to demonstrate strong early engagement, refine our personalization engine, and position eeMeds for scalable growth in future financing.

I would appreciate the opportunity for a brief conversation this week to share our vision and roadmap.

Best,

Dr. Ebot Eyong
Founder, E & E Medicals

For more information, visit https://eemedicals.com/

Explore More Publications

Continue exploring Dr. Ebot Eyong’s professional insights on healthcare regulation, FDA submissions, AI-enabled medical devices, quality systems, and global compliance strategy.

CMC & FDA Submissions

Top 10 Premarket Authorization Challenges for Medical Device Manufacturers Navigating Regulatory Complexity from Concept to Market Approval

July 9, 2026

By Dr. Eyong Ebot

Discover the top 10 premarket authorization challenges facing medical device manufacturers and learn practical strategies to accelerate FDA 510(k), De Novo, and PMA approvals.

Read Article

AI & Digital Health

Why Health Apps Aren’t Enough Anymore

June 4, 2026

by Dr. Ebot Eyong

Your sleep data sits in one place. Your glucose trends live somewhere else. Your stress levels are isolated. Each app tells you what’s happening in its own narrow world—but your body doesn’t work that way. Health is interconnected. Poor sleep affects glucose. Stress impacts blood pressure. Mental health influences weight. When these signals are disconnected, you’re left guessing.

Read Article

Cybersecurity & Cloud Systems

Cybersecurity Documentation for Premarket Approval (PMA) Submissions

February 9, 2024

By Dr. Ebot Eyong

Cybersecurity documentation is vital for PMA submissions to the FDA, ensuring device safety and effectiveness. This article outlines cybersecurity risk assessment, security controls, SBOM, vulnerability disclosure, incident response planning, labeling, monitoring, and documentation requirements.

Read Article

AI & Digital Health

AI Validation Requirements for FDA Submissions: What Companies Must Know Now!!

May 11, 2024

By Dr. Ebot Eyong

AI is reshaping medical devices, but regulatory hurdles remain. Validation is vital for FDA approval, especially with the complexities of machine learning. This article outlines key requirements including data quality, performance testing, clinical validation, transparency, risk management, lifecycle management, and real-world monitoring.

Read Article

View All Publications